TargetMol

Clavulanic Acid

Product Code:
 
TAR-T19860
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T19860-5mg5mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Clavulanic Acid is an antibiotic compound. It acts as a mechanism-based β-lactamase inhibitor.
CAS:
58001-44-8
Formula:
C8H9NO5
Molecular Weight:
199.162
Purity:
0.98
SMILES:
[H][C@@]12CC(=O)N1[C@@H](C(O)=O)C(O2)=CCO

References

1. Burch DGS, Sperling D. Amoxicillin-current use in swine medicine. J Vet Pharmacol Ther. 2018 Jan 19. doi: 10.1111/jvp.12482. [Epub ahead of print] Review. PubMed PMID: 29352469. 2. Bonet M, Ota E, Chibueze CE, Oladapo OT. Routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity. Cochrane Database Syst Rev. 2017 Nov 13;11:CD012137. doi: 10.1002/14651858.CD012137.pub2. Review. PubMed PMID: 29190037. 3. Fiore M, Maraolo AE, Gentile I, Borgia G, Leone S, Sansone P, Passavanti MB, Aurilio C, Pace MC. Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis. World J Hepatol. 2017 Oct 28;9(30):1166-1175. doi: 10.4254/wjh.v9.i30.1166. Review. PubMed PMID: 29109849; PubMed Central PMCID: PMC5666303. 4. Cheesman MJ, Ilanko A, Blonk B, Cock IE. Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution? Pharmacogn Rev. 2017 Jul-Sep;11(22):57-72. doi: 10.4103/phrev.phrev_21_17. Review. PubMed PMID: 28989242; PubMed Central PMCID: PMC5628525.